Detalhe da pesquisa
1.
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Am J Hematol
; 98(12): 1856-1868, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772428
2.
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations.
Br J Haematol
; 194(4): 708-717, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296432
3.
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
EClinicalMedicine
; 65: 102307, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033506
4.
Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
Cancers (Basel)
; 14(14)2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35884436
5.
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
J Hematol Oncol
; 15(1): 116, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36028857
6.
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Leukemia
; 35(12): 3444-3454, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725454